Toward a Better Understanding of Brain Lesions during Metachromatic Leukodystrophy Evolution

References

1. 1.↵
   1. Cheon JE,
   2. Kim IO,
   3. Hwang YS,
   4. et al

   . Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics 2002; 22: 461– 76

   PubMedWeb of Science
2. 2.↵
   1. Fluharty AL

   . Arylsulfatase A deficiency. Gene Reviews 2006. [Internet]. Seattle: University of Washington, Seattle; 1993– 2006 May 30 [updated 2011 Aug 25]
3. 3.↵
   1. Demaerel P,
   2. Faubert C,
   3. Wilms G,
   4. et al

   . MR findings in leukodystrophy. Neuroradiology 1991; 33: 368– 71

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Cartier N,
   2. Aubourg P.

   . Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy. Brain Pathol 2010; 20: 857– 62

   PubMedWeb of Science
5. 5.↵
   1. Eichler F,
   2. Grodd W,
   3. Grant E,
   4. et al

   . Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am J Neuroradiol 2009; 30: 1893– 97

   Abstract/FREE Full Text
6. 6.↵
   1. Friede RL

   , ed. Developmental Neuropathology. Berlin: Springer-Verlag; 1989: 461– 469
7. 7.↵
   1. Molander-Melin M,
   2. Pernber Z,
   3. Franken S,
   4. et al

   . Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice. J Neurocytol 2004; 33: 417– 27

   PubMedWeb of Science
8. 8.↵
   1. Wittke D,
   2. Hartmann D,
   3. Gieselmann V,
   4. et al

   . Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution. Acta Neuropathol 2004; 108: 261– 71 Epub 2004 Aug 20

   CrossRefPubMed
9. 9.↵
   1. Barkovich AJ,
   2. Kjos BO.

   . Normal postnatal development of the corpus callosum as demonstrated by MR imaging. AJNR Am J Neuroradiol 1988; 9: 487– 91

   Abstract/FREE Full Text
10. 10.↵
    1. Rakic P,
    2. Yakovlev PI.

    . Development of the corpus callosum and cavum septi in man. J Comp Neurol 1968; 132: 45– 72

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Engelbrecht V,
    2. Scherer A,
    3. Rassek M,
    4. et al

    . Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 2002; 222: 410– 18

    PubMedWeb of Science
12. 12.↵
    1. Sener RN.

    . Metachromatic leukodystrophy: diffusion MR imaging and proton MR spectroscopy. Acta Radiol 2003; 44: 440– 43

    FREE Full Text
13. 13.↵
    1. Kim TS,
    2. Kim IO,
    3. Kim WS,
    4. et al

    . MR of childhood metachromatic leukodystrophy. AJNR Am J Neuroradiol 1997; 18: 733– 38

    Abstract/FREE Full Text
14. 14.↵
    1. Loes DJ,
    2. Hite S,
    3. Moser H,
    4. et al

    . Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994; 15: 1761– 66

    Abstract/FREE Full Text
15. 15.↵
    1. Sener RN.

    . Metachromatic leukodystrophy: diffusion MR imaging findings. AJNR Am J Neuroradiol 2002; 23: 1424– 26

    Abstract/FREE Full Text
16. 16.↵
    1. Patay Z.

    . Diffusion-weighted MR imaging in leukodystrophies. Eur Radiol 2005; 15: 2284– 303

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Galanaud D,
    2. Aubourg P,
    3. Kalifa G,
    4. et al

    . What is your diagnosis? Metachromatic leukodystrophy. J Neuroradiol 2002; 29: 173– 75
18. 18.↵
    1. Dali C,
    2. Hanson LG,
    3. Barton NW,
    4. et al

    . Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy. Neurology 2010; 75: 1896– 903

    Abstract/FREE Full Text
19. 19.↵
    1. Kruse B,
    2. Hanefeld F,
    3. Christen HJ,
    4. et al

    . Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J Neurol 1993; 241: 68– 74

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Hayakawa K,
    2. Kanda T,
    3. Hashimoto K,
    4. et al

    . MR imaging of spastic diplegia. The importance of corpus callosum. Acta Radiol 1996; 37: 830– 36

    Abstract/FREE Full Text
21. 21.↵
    1. Iai M,
    2. Tanabe Y,
    3. Goto M,
    4. et al

    . A comparative magnetic resonance imaging study of the corpus callosum in neurologically normal children and children with spastic diplegia. Acta Paediatr 1994; 83: 1086– 90

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Panigrahy A,
    2. Barnes PD,
    3. Robertson RL,
    4. et al

    . Quantitative analysis of the corpus callosum in children with cerebral palsy and developmental delay: correlation with cerebral white matter volume. Pediatr Radiol 2005; 35: 1199– 207

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Autti T,
    2. Joensuu R,
    3. Aberg L.

    . Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology 2007; 49: 571– 78

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Bloembergen N,
    2. Purcell EM,
    3. Pound RV.

    . Nuclear magnetic relaxation. Nature 1947; 160: 475
25. 25.↵
    1. Ge Y,
    2. Jensen JH,
    3. Lu H,
    4. et al

    . Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007; 28: 1639– 44

    Abstract/FREE Full Text
26. 26.↵
    1. Neema M,
    2. Stankiewicz J,
    3. Arora A,
    4. et al

    . T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging 2007; 17: 16S– 21S

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Bakshi R,
    2. Dmochowski J,
    3. Shaikh ZA,
    4. et al

    . Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001; 185: 19– 26

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Bakshi R,
    2. Benedict RH,
    3. Bermel RA,
    4. et al

    . T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002; 59: 62– 68

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Bermel RA,
    2. Puli SR,
    3. Rudick RA,
    4. et al

    . Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005; 62: 1371– 76

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Houtchens MK,
    2. Benedict RH,
    3. Killiany R,
    4. et al

    . Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007; 69: 1213– 23

    Abstract/FREE Full Text
31. 31.↵
    1. Mesaros S,
    2. Rocca MA,
    3. Absinta M,
    4. et al

    . Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology 2008; 70: 1107– 12

    Abstract/FREE Full Text
32. 32.↵
    1. Goodman A

    . Reduced thalamic and corpus callosum areas found to correlate with cognitive impairment in childhood-onset MS. Neurology Today 2010: 10: 6
33. 33.↵
    1. Smith EE,
    2. Salat DH,
    3. Jeng J,
    4. et al

    . Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology 2011; 76: 1492– 99

    Abstract/FREE Full Text